Unique to the pediatric population, however, adverse reactions of the respiratory system were most frequently reported in the 2 to 16 year age group (18.5 %).
Accidental injuries were reported frequently in the 2 to 16 year age group (3.8 %) [see Use in Specific Populations (8.4) ].